


Ask a doctor about a prescription for OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 40 mg/12.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Olmesartan / Hydrochlorothiazide Pensa Pharma 40 mg / 12.5 mg Film-Coated Tablets EFG
Olmesartan Medoxomil / Hydrochlorothiazide
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
If you have any questions, consult your doctor or pharmacist.
Contents of the Package Leaflet
Olmesartan / Hydrochlorothiazide Pensa Pharma contains two active substances, olmesartan medoxomil and hydrochlorothiazide, which are used to treat high blood pressure (hypertension):
? Olmesartan medoxomil belongs to a group of medications called angiotensin II receptor antagonists. It lowers blood pressure by relaxing blood vessels.
? Hydrochlorothiazide belongs to a group of medications called thiazide diuretics.
It lowers blood pressure by helping to remove excess fluids, increasing urine production by the kidneys.
Olmesartan / Hydrochlorothiazide will only be given if treatment with olmesartan alone has not adequately controlled your blood pressure. The combined administration of both active substances in Olmesartan / Hydrochlorothiazide Pensa Pharma helps to lower blood pressure more than if each substance were administered alone.
It may be that you are already taking medications to treat high blood pressure, but your doctor may believe it is necessary for you to take olmesartan / hydrochlorothiazide to lower it further.
High blood pressure can be controlled with medications like Olmesartan / Hydrochlorothiazide Pensa Pharma. Your doctor has probably also recommended that you make some lifestyle changes to help lower your blood pressure (such as losing weight, quitting smoking, reducing alcohol consumption, and reducing the amount of salt in your diet). Your doctor may also have recommended that you exercise regularly, such as walking or swimming. It is essential to follow your doctor's advice.
Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma:
If you think you have any of these conditions, or are unsure, do not take the tablets. Talk to your doctor and follow their advice.
Warnings and Precautions:
Consult your doctor before starting to take Olmesartan / Hydrochlorothiazide Pensa Pharma.
Before taking the tablets, tell your doctorif you are taking any of the following medications used to treat high blood pressure (hypertension):
Your doctor may want to check your kidney function, blood pressure, and blood electrolyte levels (such as potassium) at regular intervals.
See also the information under the heading "Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma".
Before taking the tablets, tell your doctorif you have any of the following health problems:
Contact your doctor if you experience any of the following symptoms:
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking Olmesartan/Hydrochlorothiazide Pensa Pharma. Your doctor will decide whether to continue treatment. Do not stop taking Olmesartan/Hydrochlorothiazide Pensa Pharma on your own.
Your doctor may want to see you more often and perform some tests if you have any of these problems.
Olmesartan / Hydrochlorothiazide Pensa Pharma may cause an increase in blood fat and uric acid levels (which can cause gout - painful swelling of the joints). Your doctor will likely want to perform a blood test from time to time to monitor these possible changes.
A change in blood levels of certain chemicals called electrolytes may occur. Your doctor will likely want to perform a blood test from time to time to monitor this possible change. Some signs of electrolyte changes are: thirst, dry mouth, muscle pain or cramps, tired muscles, low blood pressure (hypotension), feeling of weakness, slowness, fatigue, drowsiness or restlessness, nausea, vomiting, decreased need to urinate, rapid heartbeat. Tell your doctor if you notice any of these symptoms.
As with any other medication that lowers blood pressure, excessive blood pressure reduction in patients with altered blood flow to the heart or brain may cause a heart attack or stroke. Therefore, your doctor will carefully monitor your blood pressure.
If you are going to have parathyroid function tests, you should stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma before these tests are performed.
Athletes are informed that this medication contains a component that may result in a positive doping test.
You should inform your doctor if you are pregnant or think you may be pregnant. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during pregnancy, and it should not be taken if you are pregnant for more than 3 months, as it may cause serious harm to your baby if taken at this stage (see section Pregnancy).
Children and Adolescents:
Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended for children and adolescents under 18 years of age.
Use of Olmesartan / Hydrochlorothiazide Pensa Pharma with other medications:
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
In particular, inform your doctor or pharmacist about any of the following medications:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings "Do not take Olmesartan / Hydrochlorothiazide Pensa Pharma" and "Warnings and Precautions").
The lithium (medication used to treat mood changes and some types of depression) if used at the same time as olmesartan/hydrochlorothiazide may increase its toxicity. If you need to take lithium, your doctor will measure lithium levels in your blood.
Taking Olmesartan / Hydrochlorothiazide Pensa Pharma with food and drinks
Olmesartan / Hydrochlorothiazide can be taken with or without food.
Be careful when drinking alcohol while taking olmesartan / hydrochlorothiazide, as some people feel weak or dizzy. If this happens to you, do not drink any alcohol, including wine, beer, or drinks with alcohol.
Black Patients:
As with other similar medications, the blood pressure-lowering effect of Olmesartan / Hydrochlorothiazide Pensa Pharma is somewhat smaller in black patients.
Pregnancy and Breastfeeding:
Pregnancy
You should inform your doctor if you are pregnant (or think you may be pregnant). Your doctor will generally advise you to stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma before becoming pregnant or as soon as you know you are pregnant, and will recommend that you take another medication instead of Olmesartan / Hydrochlorothiazide Pensa Pharma. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during pregnancy, and it should not be taken after the third month of pregnancy, as it may cause serious harm to your baby if taken from that point on.
Breastfeeding
Tell your doctor if you are breastfeeding or plan to start breastfeeding. Olmesartan / Hydrochlorothiazide Pensa Pharma is not recommended during breastfeeding, and your doctor will choose another treatment for you if you wish to breastfeed.
If you are pregnant, breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Use in Athletes
Athletes are informed that this medication contains a component (hydrochlorothiazide) that may result in a positive doping test.
Driving and Using Machines:
You may feel drowsy or dizzy while being treated for high blood pressure. If this happens, do not drive or use machines until the symptoms have disappeared. Consult your doctor.
Information about Excipients:
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
The recommended doseis 1 tablet of Olmesartan / Hydrochlorothiazide Pensa Pharma 40 mg/12.5 mg per day. If your blood pressure is not adequately controlled, your doctor may change the dose to 1 tablet of Olmesartan / Hydrochlorothiazide Pensa Pharma 40 mg/25 mg per day.
Take the tablets with water. If possible, take your dose at the same time every day, for example, at breakfast time. It is essential to continue taking Olmesartan / Hydrochlorothiazide Pensa Pharma until your doctor tells you to stop.
If you take more Olmesartan / Hydrochlorothiazide Pensa Pharma than you should:
If you take more tablets than you should or if a child accidentally ingests one or more tablets, contact your doctor immediately or go to the emergency department of the nearest hospital and take the medication package with you.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
If you forget to take Olmesartan / Hydrochlorothiazide Pensa Pharma:
If you forget to take a dose, take the usual dose the next day. Do not take a double dose to make up for forgotten doses.
If you stop taking Olmesartan / Hydrochlorothiazide Pensa Pharma:
It is essential to continue taking olmesartan / hydrochlorothiazide unless your doctor tells you to stop.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
However, the following adverse effects may be serious:
Olmesartan / Hydrochlorothiazide Pensa Pharma is a combination of two active ingredients. The following information first describes the adverse effects reported so far with the olmesartan / hydrochlorothiazide combination (in addition to those already mentioned) and, secondly, the known adverse effects of the two active ingredients separately.
These are other known adverse effects withOlmesartan/ HydrochlorothiazidePensa Pharma:
If these effects occur, they are often mild and it is not necessary to interrupt treatment.
Common adverse effects (may affect up to 1 in 10 people):
Dizziness, weakness, headache, fatigue, chest pain, swelling of ankles, feet, legs, hands, or arms.
Uncommon adverse effects (may affect up to 1 in 100 people):
Fast and intense heartbeat (palpitations), rash, eczema, vertigo, cough, indigestion, abdominal pain, nausea, vomiting, diarrhea, muscle cramps, and muscle pain, joint pain, arm and leg pain, back pain, erection problems in men, blood in urine.
Also, some changes in blood test results have been observed, including:
Increased levels of fat in the blood, increased urea or uric acid in the blood, increased creatinine, increased or decreased potassium levels in the blood, increased calcium levels in the blood, increased blood sugar, increased liver function test values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Rare adverse effects (may affect up to 1 in 1,000 people):
Feeling unwell, changes in consciousness, skin swelling (hives), acute kidney failure.
Also, some changes in blood test results have been observed, including:
Increased blood urea nitrogen, decreased hemoglobin and hematocrit values. Your doctor will monitor you with a blood test and tell you if you need to take any action.
Additional adverse effects reported with the use of olmesartan medoxomil or hydrochlorothiazide alone, but not withOlmesartan/ HydrochlorothiazidePensa Pharmaor at a higher frequency:
Olmesartan medoxomil:
Common adverse effects (may affect up to 1 in 10 people):
Bronchitis, cough, nasal congestion and secretion, sore throat, abdominal pain, indigestion, diarrhea, nausea, gastroenteritis, joint or bone pain, back pain, blood in urine, urinary tract infection, flu-like symptoms, pain.
Also, some changes in blood test results have been observed, including:
Increased levels of fat in the blood, increased urea or uric acid in the blood, increased liver or muscle function test values.
Uncommon adverse effects (may affect up to 1 in 100 people):
Rapid allergic reactions that can affect the whole body and cause breathing problems, as well as a rapid drop in blood pressure that can lead to fainting (anaphylactic reactions), facial inflammation, angina (chest pain or discomfort known as angina pectoris), feeling unwell, allergic skin rash, itching, exanthema (skin rash), skin swelling (hives).
Also, some changes in blood test results have been observed, including:
Decreased number of a type of blood cell called platelets (thrombocytopenia).
Rare adverse effects (may affect up to 1 in 1,000 people):
Kidney function impairment, lack of energy.
Also, some changes in blood test results have been observed, including:
Increased potassium in the blood.
Intestinal angioedema: swelling in the intestine that presents symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Hydrochlorothiazide:
Very common adverse effects (may affect more than 1 in 10 people):
Changes in blood tests, including increased fat in the blood and uric acid levels.
Common adverse effects (may affect up to 1 in 10 people):
Feeling of confusion, abdominal pain, stomach discomfort, feeling of bloating, diarrhea, nausea, vomiting, constipation, glucose in urine.
Also, some changes in blood test results have been observed, including:
Increased creatinine, urea, calcium, and sugar levels in the blood, decreased chloride, potassium, magnesium, and sodium levels in the blood. Increased serum amylase (hyperamylasemia).
Uncommon adverse effects (may affect up to 1 in 100 people):
Decreased or lost appetite, severe breathing difficulties, anaphylactic skin reactions (hypersensitivity reactions), worsening of pre-existing myopia, erythema, skin reactions due to light sensitivity, itching, purple spots or patches on the skin due to small hemorrhages (purpura), skin swelling (hives).
Rare adverse effects (may affect up to 1 in 1,000 people):
Inflammation and pain of the salivary glands, decreased number of white blood cells, decreased number of platelets in the blood, anemia, bone marrow depression, restlessness, depression, sleep problems, feeling of loss of interest (apathy), tingling and numbness, seizures (convulsions), yellowish perception of objects when looking at them, blurred vision, dry eyes, irregular heartbeat, inflammation of blood vessels, blood clots (thrombosis or embolism), lung inflammation, fluid accumulation in the lungs, pancreatitis, jaundice, infection in the gallbladder, lupus erythematosus symptoms such as skin rash, joint pain, and cold hands and fingers, allergic skin reactions, skin peeling and blisters, non-infectious kidney inflammation (interstitial nephritis), fever, muscle weakness (which sometimes causes movement disorders).
Very rare adverse effects (may affect up to 1 in 10,000 people):
Electrolyte imbalance that can cause an abnormally low level of chloride in the blood (hypochloremic alkalosis), intestinal obstruction (paralytic ileus).
Acute respiratory distress (signs include severe respiratory distress, fever, weakness, and confusion).
Adverse effects of unknown frequency (cannot be estimated from available data):Decreased vision and eye pain due to high pressure [possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma], skin and lip cancer (non-melanoma skin cancer).
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiration date that appears on the packaging and blister pack (after "CAD.:"). The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition ofOlmesartán/ HydrochlorothiazidePensa Pharma
The active ingredient is olmesartan and hydrochlorothiazide. Each tablet contains 40 mg of olmesartán (in the form of olmesartán medoxomil) and 12.5 mg of hydrochlorothiazide.
The other components are:
See section 2: information on excipients
Appearance of the product and package contents
Olmesartán / Hydrochlorothiazide Pensa Pharma 40 mg / 12.5 mg are film-coated tablets, yellow, oblong, biconvex with logo D3 on one side.
They are presented in aluminum-aluminum blister packs. Each pack contains 28 film-coated tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer:
Laboratorios Cinfa, S.A.
Olaz-Chipi, 10 - Polígono Industrial Areta 31620
Huarte-Pamplona, Spain
Date of the last revision of this prospectus:February 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products. http://www.aemps.gob.es
The average price of OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 40 mg/12.5 mg FILM-COATED TABLETS in December, 2025 is around 20.18 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for OLMESARTAN/HYDROCHLOROTHIAZIDE PENSA PHARMA 40 mg/12.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.